- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01927770
A Study of Consent Forms for Whole Exome and Whole Genome Sequencing
Randomized Trial of Consent Interventions for NIH Whole Exome and Whole Genome Sequencing Studies
Background:
The purpose of this study is to investigate the process of consenting participants to whole exome/genome sequencing and its outcomes. It is unknown how best to consent people to this new technology. NO GENOME SEQUENCING IS OFFERED AS PART OF THIS STUDY. This protocol is a companion to other NIH studies that involve genomic sequencing. Participants must be enrolled in a parent NIH study that is collaborating on this consent study to be eligible. Currently this involves only one NIH study.
Objectives:
- To learn the best way to help participants understand sequencing, so they can decide whether to join studies that use it.
Eligibility:
- Adults at least 18 years old who are enrolled in a National Institutes of Health (NIH) study that uses WES/WGS.
- Adults at least 18 years old whose children are enrolled in an NIH study that uses WES/WGS.
Design:
- Participants will take part in the study either in person or over the phone.
- Participants will review two sequencing consent forms with a genetic counselor.
- Before and after meeting with the counselor, participants will answer several questions about sequencing. Each questionnaire will take about 15 minutes.
- Six weeks later, participants will answer questions about sequencing. This will take about 15 minutes.
Study Overview
Status
Conditions
Detailed Description
Consent to participant in studies that include whole exome and whole genome sequencing (WES/WGS) studies and to receive results present challenges to achieving informed consent due to the scope, depth and uncertainty of the information. NIH Intramural studies increasingly involve WES/WGS to identify elusive primary variants. This umbrella protocol aims to compare an evidence-based consent for WES/WGS to a standard consent in collaboration with ongoing and future NIH studies. An equivocal hypothesis will be tested to evaluate whether informed choice and perceptions of uncertainty differ between two consent
groups. A mixed-methods design is proposed that starts with a qualitative mental-model pilot
study to revise an expert opinion consent intervention by integrating lay-person response
preferences. Following development of this evidence-based intervention, a randomized two- factor design will be used for a quantitative survey study conducted in conjunction with a
number of NIH studies conducting WES/WGS to test for differences between two consent
models. A descriptive analysis of the audiotaped consent process will also be conducted to
assess differences in the content or extent of the process, and related outcomes of satisfaction and decisional conflict will also be assessed.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20892
- National Institutes of Health Clinical Center, 9000 Rockville Pike
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
- INCLUSION CRITERIA:
Eligible adults (greater than or equal to 18 years of age) consenting to enroll in an NIH study that includes WES/WGS. Parents of eligible children (<18 years of age) consenting to enroll their child(ren) in an NIH study that includes WES/WGS. Participants must be cognitively able to consent and fluent in written and spoken English.
EXCLUSION CRITERIA:
Children (<18 years of age). Non-English speaking participants (until the study has evolved to be able to use translations of the interventions into Spanish).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
WES/WGS
Eligible adults (or parents of eligible children) consenting to enroll in an NIH study thatincludes WES/WGS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
A
Time Frame: Ongoing
|
To contrast the efficacy of an evidence-based streamlined consent model (based upon the integration of an expert opinion model and laypersons responses using a mental- models approach) to a standard NIH consent in consenting adult and parent participants to undergo WES/WGS within NIH Intramural studies.
|
Ongoing
|
B
Time Frame: Ongoing
|
To quantitatively assess changes in understanding, perceptions of uncertainty and informed choice between the two consent interventions, assuming equivalency.
|
Ongoing
|
C
Time Frame: Ongoing
|
To describe satisfaction,decisional conflict and residual questions and concerns following use of each consent intervention.
|
Ongoing
|
D
Time Frame: Ongoing
|
To compare the content, dialogue and time spent in the consent discussions between interventions.
|
Ongoing
|
Collaborators and Investigators
Investigators
- Principal Investigator: Julie Sapp, National Human Genome Research Institute (NHGRI)
Publications and helpful links
General Publications
- Biesecker LG, Mullikin JC, Facio FM, Turner C, Cherukuri PF, Blakesley RW, Bouffard GG, Chines PS, Cruz P, Hansen NF, Teer JK, Maskeri B, Young AC; NISC Comparative Sequencing Program; Manolio TA, Wilson AF, Finkel T, Hwang P, Arai A, Remaley AT, Sachdev V, Shamburek R, Cannon RO, Green ED. The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res. 2009 Sep;19(9):1665-74. doi: 10.1101/gr.092841.109. Epub 2009 Jul 14.
- Ayuso C, Millan JM, Mancheno M, Dal-Re R. Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process. Eur J Hum Genet. 2013 Oct;21(10):1054-9. doi: 10.1038/ejhg.2012.297. Epub 2013 Jan 16.
- Dormandy E, Michie S, Hooper R, Marteau TM. Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices? Int J Epidemiol. 2005 Apr;34(2):346-52. doi: 10.1093/ije/dyi021. Epub 2005 Feb 28.
- Turbitt E, Chrysostomou PP, Peay HL, Heidlebaugh AR, Nelson LM, Biesecker BB. A randomized controlled study of a consent intervention for participating in an NIH genome sequencing study. Eur J Hum Genet. 2018 May;26(5):622-630. doi: 10.1038/s41431-018-0105-7. Epub 2018 Feb 16.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 130171
- 13-HG-0171
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Whole Genome Sequencing
-
University of Alabama at BirminghamUniversity of Louisville; University of Mississippi Medical Center; Woman's Hospital... and other collaboratorsRecruitingWhole Genome SequencingUnited States
-
Washington University School of MedicineAmerican Society of HematologyRecruitingMyelodysplastic Syndromes | Whole Genome SequencingUnited States
-
Washington University School of MedicineRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Whole Genome SequencingUnited States
-
Centre Hospitalier Universitaire DijonRecruitingPrenatal | Genome-wide High Throughput SequencingFrance
-
Geneplus-Beijing Co. Ltd.Beijing Hospital; Emergency General HospitalRecruitingPulmonary Nodule, Solitary | Whole-genome Methylation SequencingChina
-
Seoul National University HospitalUnknownWhole Genome Sequencing | Nontuberculous Mycobacterium InfectionKorea, Republic of
-
Lei LiUnknownCervical Adenocarcinoma | Human Papillomavirus | Metabolome | Prognosis | Whole Exome Sequencing | Tumorigenesis | Transcriptome | Genome-wide Association StudyChina
-
The Second Affiliated Hospital of Chongqing Medical...Cellomics International LimitedRecruitingHepatocellular Carcinoma | Circulating Tumor Cell | Whole Genome SequencingChina
-
Number 2 Children's Hospital, Ho Chi Minh CityUniversity Hospital, Geneva; Swiss National Science Foundation; University of... and other collaboratorsRecruitingEpileptic Encephalopathy | Whole Exome SequencingVietnam